Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **extracellular matrix (ECM) of dermal tissue** is a complex, non-cellular network of proteins, glycoproteins, proteoglycans, and polysaccharides that fills the intercellular space of the skin’s dermal layer[2][3][7]. Its principal components include collagens (primarily type I and III), elastin, fibronectin, hyaluronan, and various proteoglycans and matricellular proteins[2][6][3]. The ECM provides critical **structural support**, maintains tissue architecture, and underpins the **mechanical stability** and elasticity of skin[2][3][6]. Beyond these physical roles, it **regulates a range of biological functions** including cell adhesion, migration, proliferation, and the storage and controlled release of growth factors crucial for tissue homeostasis, wound healing, and regeneration[1][2][5]. Dermal ECM is dynamically remodeled in physiological processes (growth, aging, repair) and in disease (e.g., chronic wounds, fibrosis, keloids, inflammatory skin disorders, and cancer metastasis)[2][5][6]. ECM composition and biomechanical properties are highly **tissue- and condition-specific** and are altered significantly in pathological states[2][5]. Disruption of dermal ECM integrity can lead to clinical challenges such as impaired healing or aberrant scarring[6][2]. The ECM is not a single molecular target for therapeutics; instead, interventions usually target its components, structure, or modulating enzymes rather than the matrix as a whole. **Note:** - "Extracellular matrix of dermal tissue" is **not a single molecule, receptor, or canonical drug target**, but a structural and functional ensemble in connective tissue[2][3][7]. - The group term does not fit standard definitions of molecular drug targets such as receptors or enzymes, but its components can individually be therapeutic targets or diagnostic biomarkers[2][6]. - This entry is marked **is_incorrect: true** due to the lack of specificity as a discrete molecular entity.
Modulation or replacement of ECM structure (e.g., providing scaffold in wounds); Regulation of cell-matrix interactions (e.g., inhibiting enzymes that degrade ECM)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix of dermal tissue (ECM).